PhonePe IPO Review

Status (upcoming): PhonePe received SEBI approval on 20 January 2026 and filed its updated DRHP. The IPO is structured as a 100% Offer for Sale of up to 5.06 crore shares no fresh issue expected to raise around ₹12,000 crore at a valuation of roughly $12–15 billion. Selling shareholders include Walmart (paring about 9%), with Tiger Global and Microsoft exiting fully. In March 2026, PhonePe postponed the listing citing volatile markets and geopolitical uncertainty, so the date, price band and lot size remain unannounced. There's no GMP yet, since no price band exists.

About the Company

Tap your phone to pay for chai, split a bill with a friend, send money to your mother and there's roughly a one in two chance you did it through PhonePe. It's the app that turned UPI into a daily habit for hundreds of millions of Indians.

Founded in 2015 and spun out of Flipkart, PhonePe is India's largest digital payments platform. It has led UPI transactions for 58 months straight, with around 49% market share well ahead of Google Pay and fellow fintech Paytm. It serves about 65.7 crore registered users and 4.7 crore merchants, reaching over 98% of India's pin codes.

But payments alone barely make money UPI carries no transaction fee. So PhonePe uses that massive reach to sell higher margin financial products: lending and insurance through partners, wealth and mutual funds, stock broking via Share.Market, and its Indus Appstore. The payments app is the funnel; financial services are where the profit is meant to come from. Track its IPO updates on the IPO GMP Live homepage.

Financial Snapshot

Read the raw numbers carefully here. PhonePe's revenue has grown fast from about ₹2,914 crore in FY23 to ₹5,064 crore in FY24 to ₹7,115 crore in FY25, a rare pace at this scale. But it still reports statutory losses: ₹1,996 crore in FY24, narrowing to ₹1,727 crore in FY25.

The crucial nuance: most of that loss is a one time ESOP cost from shifting the company's base to India, not the operating business bleeding cash. On an adjusted basis, PhonePe actually turned profitable in FY24, with the core payments business making money. Strip out the accounting noise and this is a far healthier company than the loss line suggests.

One thing to weigh, though. Because the IPO is a 100% offer for sale, PhonePe raises no money from it every rupee goes to Walmart, Tiger Global and Microsoft. The company already sits on around ₹1,100 crore of cash and says it doesn't need the funds. So you're being asked to buy shares that early backers are selling, not to fund the next phase of growth. That's not automatically bad, but it shapes how you read the deal.

Strengths

• It dominates UPI. PhonePe holds around 49% of UPI transactions and has been number one for 58 straight months, with 65.7 crore users and 4.7 crore merchants. That scale creates powerful network effects that rivals have struggled to break.
• Fast growth, and profitable underneath. Revenue grew at roughly 56% a year to ₹7,115 crore in FY25, and on an adjusted basis the company turned profitable in FY24 the core payments business already makes money once one-off ESOP costs are excluded.
• High-margin diversification is building. Beyond payments, PhonePe earns from lending and insurance distribution, wealth and mutual funds, Share.Market broking and the Indus Appstore. These higher margin services are where the real profit pool lies.
• Strong backing and a cash cushion. Walmart owned and rated among India's most valuable brands, PhonePe sits on about ₹1,100 crore of cash and doesn't need IPO proceeds to operate a sign of financial strength rare for a fintech this young.

Risks

• The 30% UPI cap is the defining risk. NPCI has proposed limiting any single app to 30% of UPI volumes and PhonePe sits near 49%. The rule is deferred to December 2026, but if enforced, it could sharply restrict user onboarding and growth.
• It's a 100% exit for backers. The entire issue is an offer for sale by Walmart, Tiger Global and Microsoft, so no money goes to the company. You'd be buying shares that early investors are selling, not funding future growth.
• Still loss-making on paper, with thin payments monetisation. Statutory loss was ₹1,727 crore in FY25, and UPI itself earns almost nothing. Profitability rests on cross-selling lending and insurance, which has to keep scaling.
• Heavy regulatory and partner dependence. UPI pricing, lending commissions and insurance are all regulated, and PhonePe relies on just three sponsor banks (Yes, Axis, ICICI) to connect to UPI. The listing has already been postponed once on market conditions.

Should You Apply?

There's nothing to apply for yet. PhonePe has SEBI approval but postponed the listing in March 2026, so the date, price band and lot size are all still pending. This is one to track, not act on.

When the price band arrives, here's the lens to use.

Conservative investors — wait for the valuation and watch how the 30% UPI cap question resolves. That single regulatory issue could define the stock.

Moderate investors — the dominance and adjusted profitability are attractive, but a 100% offer for sale at a steep valuation needs a sensible price to be worth a lot.

Aggressive investors — this will be one of the year's biggest fintech listings, so demand could be strong; watch the GMP and grey-market cues once it's live.

Honest take: India's UPI king with a real moat but it's an exit for its backers, priced richly, with a regulatory cloud overhead. Wait for the number.

IPO Objects of the Issue

This is a 100% offer-for-sale, so PhonePe receives no proceeds. The entire amount goes to the selling shareholders. Exact figures will be confirmed in the final RHP once the price band is set.

Contact Details

PhonePe Ltd. Bengaluru, Karnataka, India 🌐 www.phonepe.com

IPO Registrar — KFin Technologies Ltd. 📞 040-6716 2222 / 040-7961 1000 📧 einward.ris@kfintech.com 🌐 www.kfintech.com

Lead Manager: Kotak Mahindra Capital (with JP Morgan, Citigroup, Morgan Stanley, Axis Capital, Goldman Sachs, Jefferies and JM Financial)

Related IPO reviews: Tata Capital IPO · HDB Financial Services IPO · Bajaj Housing Finance IPO · Hyundai Motor India IPO · Meesho IPO · Lenskart IPO · Zepto IPO · Vahh Chemicals IPO

This page is not investment advice. GMP is indicative only and unofficial. Please consult a SEBI-registered financial advisor before investing.